Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (11-20 of 936) with videos related to

Pageof 94
Sort By:
Swiss Medical Weekly|May 25, 2011
Novel diagnostic and therapeutic approaches to malignant gliomaMichael Weller
Neuro-Oncology|April 28, 2012
More on the immune privilege of glioblastomaMichael Weller
Neuro-Oncology|February 20, 2010
Temozolomide and MGMT forever?Michael Weller
Neuro-Oncology|February 23, 2013
Assessing the MGMT status in glioblastoma: one step forward, two steps back?Michael Weller
Archives of Neurology|June 12, 2013
Primary central nervous system tumors: pathogenesis and therapyMichael Weller
Neuro-Oncology|September 24, 2010
Chemotherapy for low-grade gliomas: when? how? how long?Michael Weller
Oncology Research and Treatment|August 21, 2014
Primary central nervous system lymphoma in the elderlyMichael Weller
Onkologie|June 29, 2007
Radiochemotherapy for brain metastasis: how to define a role for temozolomideMichael Weller
MMW Fortschritte Der Medizin|September 19, 2022
Michael Weller
Neuro-Oncology|October 26, 2012
Angiogenesis inhibition: quo vadis?Michael Weller
Pageof 94

Showing results (11-20 of 936) with videos related to

Sort By:
Pageof 94
Swiss Medical Weekly|May 25, 2011
Novel diagnostic and therapeutic approaches to malignant gliomaMichael Weller
Neuro-Oncology|April 28, 2012
More on the immune privilege of glioblastomaMichael Weller
Neuro-Oncology|February 20, 2010
Temozolomide and MGMT forever?Michael Weller
Neuro-Oncology|February 23, 2013
Assessing the MGMT status in glioblastoma: one step forward, two steps back?Michael Weller
Archives of Neurology|June 12, 2013
Primary central nervous system tumors: pathogenesis and therapyMichael Weller
Neuro-Oncology|September 24, 2010
Chemotherapy for low-grade gliomas: when? how? how long?Michael Weller
Oncology Research and Treatment|August 21, 2014
Primary central nervous system lymphoma in the elderlyMichael Weller
Onkologie|June 29, 2007
Radiochemotherapy for brain metastasis: how to define a role for temozolomideMichael Weller
MMW Fortschritte Der Medizin|September 19, 2022
Michael Weller
Neuro-Oncology|October 26, 2012
Angiogenesis inhibition: quo vadis?Michael Weller
Pageof 94